MusclePharm – Global Sports Nutrition Brands & IP Portfolio For Sale

Metis Partners presents an exciting opportunity to acquire the intellectual property (“IP”) portfolio owned by MusclePharm Corporation (“MusclePharm” or the “Company”), a highly recognizable global sports nutrition business.

The MusclePharm and FitMiss brands underpin a range of sports nutrition products and energy drinks, which have been sold in over 100 countries and nationwide in the United States, including Costco and Walmart, as well as through over 100 online stores, notably, bodybuilding.com and Amazon. The MusclePharm brand has a 15-year track record and has benefited from high-profile endorsements from athletes and fitness icons including Tiger Woods and Arnold Schwarzenegger.

Operating two main consumer brands sold globally, this presents a unique opportunity to enter the sports nutrition market, valued at $42.9 billion globally in 2022 and expected to grow at a CAGR [1] of 7.4% from 2023 to 2030 (Grand View Research).

[1] Compound Annual Growth Rate

The Opportunity Highlights

  • Acquire globally recognized, sports nutrition brand, MusclePharm, which has achieved significant exposure through endorsements and partnerships with global superstars and sporting icons
  • Acquire an IP portfolio underpinning a product range that is in-demand, having generated almost $200m revenue over the last three financial years
  • Be able to leverage a significant social media [1] following of sports enthusiasts, including 577k followers on Instagram, circa 314k followers on Twitter, a Facebook account with circa 633k likes, a Tik Tok account and an Amazon store
  • Own the FitMiss product brand uniquely developed for female athletes, which has been a leading brand in the female nutrition and performance sector since its launch in 2017
  • Access a dynamic global market valued at $42.9 billion, which is expected to grow at a CAGR [2] of 7.4% from 2023 to 2030 (Grand View Research)

Contact Us

To receive an IP Asset Highlights document and access to the confidential data room, please contact Emre Turan at emre@metispartners.com and +44 (0) 141 353 3011 or +1 858 848 6911, or Molly Froschauer at mfroschauer@sherwoodpartners.com and +1 310 295 2130.

 [1]  The availability and extent of these IP assets can be confirmed during the sales process [2] Compound Annual growth Rate

Sales Process

Metis Partners and Sherwood Partners have been instructed to seek offers for the Company’s Registered Intellectual Property portfolio and other collateral by Empery Tax Efficient, LP, as agent for holders of secured notes issued by the Company, through an UCC Article 9 (foreclosure) process via an auction to be conducted in Las Vegas, Nevada, and via online participation. Please be advised that any parties wishing to attend the auction, set for December 15, 2022 at 1pm PST, must inform Metis Partners or Sherwood Partners of their intention to do so by December 13, 2022.

To receive an IP Asset Highlights document and access to the confidential data room, please contact Emre Turan at emre@metispartners.com